ANGELA ZIEGLER: Open Payments
NPI 1891128682 · ARKANSAS CITY, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$247 in 13 payments from 9 companies in 2025. Trend: 2023 $328 · 2024 $232 · 2025 $247
Food & beverage: $247
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $53 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $37 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $36 |
| Bioventus LLC | 1 | $26 |
| Vanda Pharmaceuticals Inc. | 1 | $25 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| Novo Nordisk Inc | 1 | $18 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $14 |
| Exact Sciences Corporation | 1 | $14 |
Products named: QULIPTA, Kerendia, JARDIANCE, EXOGEN ULTRASOUND BONE HEALING SYSTEM, FANAPT, REXULTI, UBRELVY, CAPLYTA.
Industry payments across KS — which companies pay providers there.
